AIM: to accelerate innovation in drug development for children and adolescents with cancer
The ACCLERATE international platform provides a transparent forum to discuss and address, in a timely fashion, overarching issues in the development of innovative anticancer medicines for children and adolescents with cancer. The ultimate goal is an improvement in the outcome of these children and adolescents.
Patients and parent’s organizations, academic paediatric oncologists and haematologists and researchers, representatives from pharmaceutical companies, regulatory networks and health technology assessment authorities are all equal members of ACCELERATE.
In June 2018, the ACCELERATE platform has been re-organized to strengthen international cooperation in order to improve global development of new paediatric oncology drugs.